Inmune Bio, Inc.

INMB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 21 employees
347
SEC Filings
$2
Close 2026-09-23
21
Employees

Business Summary

INmune Bio is a clinical-stage biotechnology company focused on reprogramming the innate immune system to treat diseases driven by chronic inflammation and immune dysfunction. Its lead product, CORDStrom, is a pooled human umbilical cord-derived mesenchymal stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB). Additional programs include XPro1595, targeting neuroinflammation in Alzheimer's Disease, and INKmune, an NK cell-priming platform for metastatic castrate-resistant prostate cancer.

Latest Stock Quote

INMB 2026-09-23 $2 O:$2.15 H:$2.175 L:$1.99 Vol:0.5M VWAP:$2.0344
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-21

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001213900-26-036370EDGAR60K words
2025-03-272024-12-310001013762-25-003354EDGAR63K words
2024-03-282023-12-310001213900-24-027206EDGAR63K words
2023-03-022022-12-310001213900-23-016875EDGAR63K words
2022-03-032021-12-310001213900-22-010573EDGAR—
2021-03-042020-12-310001213900-21-013456EDGAR—
2020-03-112019-12-310001213900-20-005916EDGAR—
2019-03-292018-12-310001640334-19-000466EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001213900-26-086135EDGAR14K words
2025-10-302025-09-300001213900-25-104141EDGAR20K words
2025-08-072025-06-300001213900-25-073077EDGAR22K words
2025-05-082025-03-310001213900-25-041072EDGAR16K words
2024-10-312024-09-300001213900-24-092861EDGAR20K words
2024-08-012024-06-300001213900-24-064076EDGAR18K words
2024-05-092024-03-310001213900-24-041286EDGAR16K words
2023-11-012023-09-300001213900-23-082167EDGAR19K words
2023-08-072023-06-300001213900-23-064057EDGAR18K words
2023-05-032023-03-310001213900-23-035972EDGAR16K words
2022-11-022022-09-300001213900-22-068637EDGAR—
2022-08-032022-06-300001213900-22-044453EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-140001213900-26-099700EDGAR1K words
2026-07-310001213900-26-083961EDGAR1K words
2026-02-270001213900-26-021120EDGAR5K words
2026-02-230001213900-26-019321EDGAR1K words
2026-02-190001213900-26-018396EDGAR1K words
2026-02-130001213900-26-016385EDGAR1K words
2026-01-270001213900-26-008204EDGAR2K words
2025-12-230001213900-25-125282EDGAR1K words
2025-12-190001213900-25-123880EDGAR24K words
2025-12-100001213900-25-120067EDGAR1K words

347 total filings indexed. 317 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

rare-pediatric-diseases-(rdeb) neurodegenerative-diseases-(alzheimer's-disease) oncology-(metastatic-castrate-resistant-prostate-cancer) neuroinflammation innate-immune-system-therapeutics cgmp-manufacturing

Company Identity

CIK0001711754
TickerINMB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV
Websitehttps://www.inmunebio.com
Listed2019-02-04

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 0fcde665c505b358edf126d5541d28d0270ee810d0199b0782f5c2a5fff0785b
parent: 99b7e476f70ed07aecd0c9247834fd55681c28ced29488dd6ed1b9e3dbf74215
content hash: d1f634dcf5e2d24bcf491b5eee63dce63d0f186ea472e47a685e972c0f14c7ee
signed: 2026-09-29T12:01:51.893Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up INMB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on INMB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/INMB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.